NEW YORK (GenomeWeb News) — Genedata has opened a subsidiary in Tokyo that will offer the company’s software to life sciences and pharmaceutical companies, the Swiss company said today.

 

The new subsidiary, called Genedata KK, is an effort to satisfy the demand Genedata sees for enterprise-level bioinformatics solutions and related services geared toward screening analysis and biomarker discovery for toxicogenomics research.  

 

The company said its Tokyo group will be headed by Frank Staubli.